Vaidya Sane Ayurved Laboratories logo

Vaidya Sane Ayurved Laboratories results, half year to Mar 2026

NSE: MADHAVBAUGHealthcare Equipment & Supplies

Vaidya Sane Ayurved Laboratories Limited · Face value ₹10 · Listed Feb 2022 · Issue price ₹73
Last close ₹140.00down ₹6.45 (4.40%)

Share price at the NSE close on 28 Oct 2026. Previous close ₹146.45.

28 Oct: open ₹134.00, high ₹144.00, low ₹134.00

52-week range of traded prices to 28 Oct 2026
₹134.00Low, 28 Oct 2026₹335.00High, 26 Dec 2025
Market cap
₹147 Cr
P/E
16.38
P/B
2.05
Dividend yield
Nonein the last 12 months
ROE
13.4%
Debt to equity
0.04
Volume, NSE
4,00070.0% delivered

Vaidya Sane Ayurved Laboratories filed its results for the half year to Mar 2026 on 18 May 2026 at 4:30 pm, consolidated: the company and its subsidiaries together.

Results for the half year to Mar 2026

₹ crore.Vaidya Sane Ayurved Laboratories annual results and balance sheet

Revenue
₹57 Cr+18.6% on a year ago · +14.1% on the half year before
Net profit
₹4.16 Cr+21.8% on a year ago · −14.0% on the half year before
Earnings per share
₹3.95+24.6% on a year ago · −13.4% on the half year before
Net margin
7.3%

From revenue to net profit, ₹ crore

  1. Revenue57
  2. Other income+1.4
  3. Finance costs−0.7
  4. Profit before tax4.3
  5. Tax−0.2
  6. Joint ventures0.0
  7. Net profit4.2

Vaidya Sane Ayurved Laboratories results by half year

Consolidated: the company and its subsidiaries together. Latest half year to Mar 2026. Results for the half year to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date

Revenue and net profit by half year, ₹ crore

  • Revenue
  • Net profit
511.2Sep 23480.8Mar 24423.3Sep 24483.4Mar 25504.8Sep 25574.2Mar 26
Peak revenue ₹57 Cr, half year to Mar 2026; lowest ₹42 Cr, half year to Sep 2024

Operating and net margin by half year, per cent

  • Operating margin
  • Net margin
17.3%1.7%5.3%3.8%13.8%17.3%2.3%1.7%7.8%7.1%9.7%7.3%Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26
₹ croreSep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue from operations45.699.251.148.241.848.049.957.0
41.491.348.446.436.0–41.3–
Materials and goods bought13.127.614.910.89.27.58.310.6
Employee costs10.822.013.613.310.4–9.6–
Other expenses17.541.719.922.316.4–23.4–
Operating profit before depreciation4.27.92.71.85.8–8.6–
Operating margin9.2%7.9%5.3%3.8%13.8%–17.3%–
Depreciation and amortisation1.22.61.61.61.9–3.0–
Other income0.81.40.61.10.81.01.01.4
Finance costs0.10.20.20.10.10.00.10.7
Profit before one-off items and tax3.76.41.61.34.66.36.54.3
One-off items0.00.00.0–0.0–––
Profit before tax3.76.41.61.34.65.16.54.3
1.01.60.40.51.31.81.60.2
Tax rate26.6%24.9%25.0%37.2%28.9%34.3%25.2%4.2%
Share of profit of joint ventures and associates−0.3––0.00.00.00.00.0
Net profit2.54.81.20.83.33.44.84.2
Net margin5.4%4.9%2.3%1.7%7.8%7.1%9.7%7.3%
Net margin without joint ventures and associates6.0%––1.7%7.8%7.0%9.7%7.3%
Earnings per share–––––₹3.17₹4.56₹3.95
Diluted earnings per share––––––₹4.56₹3.48
Earnings per share in rupees, restated for later splits and bonuses.

Segment results by half year

Consolidated from the half year to Mar 2026, standalone before, ₹ crore, half years to Mar 2026.Vaidya Sane Ayurved Laboratories segment results by year

  • sale of Product Activity

    Revenue, ₹ crore
    Profit, ₹ crore
  • Hospital Activity

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2025Sep 2025Mar 2026
Revenue of all businesses424453
Company revenue, as in its results464757
Revenue303138
Profit181210
Margin61.6%38.7%26.5%
Assets000
Liabilities002
Capital employed00−2
Revenue121316
Revenue434
Profit is before tax and finance costs, the way companies report their segments.